Speech-based biomarkers coupled with AI and ML also offer the potential to diagnose a range of medical conditions, however, the technology needs to mature before widespread clinical adoption.
AI speech analysis offers early diagnosis of a range of medical conditions, but further research is required
The Analyst Team
Andrew Brosnan
Principal Analyst, AI Applications in Life Sciences
Andrew is a principal analyst in Omdia’s AI & Intelligent Automation practice, with a vertical focus of AI use cases and AI business impact, primarily in healthcare and financial services.
Based in Oxford, his career of 30 years spans the professional and financial services and life sciences sectors as an IT practitioner, industry analyst, and consultant. Andrew has worked in IT for multinational organizations such as JP Morgan and Merck Pharmaceuticals and as an industry analyst and market researcher for Grant Thornton and Goldman Sachs in corporate finance and investment banking, respectively. As an industry analyst, Andrew has advised enterprises on digital transformation to improve operational efficiency, IT product selection, business case development, best practice, IT strategy, and implementation. Andrew advises tech companies on product strategy and development, competitive intelligence, use cases, corporate development strategy, and go-to-market messaging. Andrew holds a bachelor’s degree in economics from Boston University and an MBA from the University of Warwick.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Omdia Recommends
These are Omdia driven recommendations based on content that is both similar, and has been frequently visited by other users in combination with the content you are currently viewing.
Thank you
Our expert analysts will review your question and the Ask an Analyst team will get back to you. We aim to respond within 24 hours, but we’re often quicker.
Ask an Analyst
Our team of experts are here to answer your questions. From advice on market trends to a query on research point, and everything in between, we want to hear from you.
Ask an analyst is available as part of a subscription. If you'd like access, contact us today.